| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |